?? Thank you to everyone who joined us yesterday at the SIC Venture Studio #JPM event! ?? It was an inspiring event featuring a panel discussion on fundraising as women founders in biotech. Our CEO, Sophia Lugo, was joined by Ashley Zehnder, Janine Sengstack, and Xiaoxi (Sofie) Wei, with Rachael O'Meara hosting the conversation. Sophia shared an empowering perspective on navigating the challenges of fundraising in today's climate: "You have to believe that your idea is really going to change the world. VC money is just a way to get you there." Here’s to supporting innovation and lifting each other up in the biotech ecosystem! #JPM2025 #BiotechFounders #WomenInSTEM #FundraisingLeadership
关于我们
- 网站
-
www.radartx.bio
Radar Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 类型
- 私人持股
Radar Therapeutics员工
-
Svetlana Lucas
Chief Business Officer at Scribe Therapeutics
-
Shannon Dahl
Visionary Biotechnology Executive, Chief Scientific Officer, Board Advisor || Driving Innovation from Discovery to Go-to-Market || Offering Expertise…
-
Omri Amirav-Drory
General Partner at NFX
-
Thomas Lozanoski
Founding Research Scientist at Radar Therapeutics
动态
-
Join us at WuXi AppTec's #WuXiGlobalForum event tomorrow from 2:30 - 3:30 PM, where our co-founders Sophia Lugo and Eerik Kaseniit will host an executive roundtable! We're looking forward to sharing more about our work developing programmable, selectively-expressed genetic medicines. ? ?https://lnkd.in/eJ5m3X_j
-
-
We’re thrilled to announce that our CEO & Co-Founder Sophia Lugo will be speaking on the Biotech Women Founders: Raising Monster Rounds panel at the 2025 SIC Biotech Symposium during #JPM25!?Join Sophia and an inspiring group of leaders as they share insights on biotech innovation and funding strategies. Thanks to SIC Venture Studio and Stanford University School of Medicine for hosting. We’re looking forward to engaging programming throughout the symposium that showcases groundbreaking biotech advancements. We’re proud to celebrate the power of women in biotech and look forward to an impactful discussion. ?? Register here: https://lu.ma/x7iuffoo #WomenInBio #Biotech #Funding #RadarTherapeutics
Excited to see both Ashley Zehnder CEO & Co-Founder of Fauna Bio and Sophia Lugo, CEO & Co-Founder of Radar Therapeutics on this panel next week hosted by Stanford University School of Medicine next Tuesday Jan 14 during #JPM25 healthcare week. ???? 2025 SIC Biotech Symposium hosted by Stanford University, M-TRAM Graduate Program and SIC Venture Studio. Sponsored by Citizen’s Private Bank. Register for the event: ???? https://lu.ma/x7iuffoo #womeninbio #biotech #funding
-
-
Thanks, Bakar Labs and Niki Borghei, for putting together this fantastic profile of Radar! The support we’ve received from the Bakar community has been invaluable as we work toward breakthroughs in genetic medicine. We’re eager to keep pushing boundaries and invite you to follow our journey. Together, let’s redefine what’s possible in genetic medicine. ?????? #GeneticMedicine #BiotechInnovation #BakarLabs #HealthcareInnovation
#GeneticMedicine is one of the most exciting frontiers in healthcare—but it’s still stuck behind major roadblocks like sky-high costs and complex procedures. ?? ?? Enter Radar Therapeutics. CEO Sophia Lugo and her team are on a mission to revolutionize the field with a game-changing RNA-targeting technology that could make genetic treatments safer, more affordable, and accessible to far more patients. ?? ?? No more months of waiting or expensive hospital stays—this is the future of genetic medicine, and it’s coming fast. Curious to see how it all works? Read our latest #TenantSpotlight, written by Niki Borghei! https://lnkd.in/gVQ53Rh4 Eerik Kaseniit
-
We are thrilled to announce that our co-founder and CEO Sophia Lugo has been honored as the National Hispanic Institute (NHI)'s 2024 Person of the Year. ?? Sophia's journey from her high school days with the National Hispanic Institute to her role as CEO of Radar Therapeutics showcases her steadfast dedication to leadership and innovation. Her commitment to advancing biotechnology and her passion for equitable healthcare inspire us all. Join us in celebrating Sophia's achievement and the shared success of our team at Radar.??? #Leadership #Innovation #NHI #RadarTherapeutics
‘You have to believe that you can be a leader’: Sophia Lugo, NHI’s 2024 Person of the Year For full story, visit: https://lnkd.in/gea8wgdf or click link in bio!
-
-
We’re thrilled to announce that our founder Sophia Lugo has been named Founder of the Year by Mendoza Impact! ?? This recognition highlights Sophia’s vision, leadership, and dedication to advancing Radar Therapeutics. It also reflects the hard work and collective effort of the entire Radar team. We’re incredibly proud to be part of this journey and are inspired to continue pushing the boundaries of innovation in the year ahead. A big thank you to Mendoza Impact and the event sponsors for making the 2024 Mendoza Impact Awards possible.?Mendoza is dedicated to building micro-communities that drive sustainable impact by supporting diverse and female founders through hands-on programming, access to capital, and a strong alumni network. #Leadership #Innovation #FounderOfTheYear #ProudTeam #RadarTherapeutics
Funder of the Year ?? Matthew Archuleta from Connecticut Innovations ?? Matthew's intentionality towards capital allocation, best practices, and doing good with every effort is unparalleled. As a Mendoza Impact Fellow Alumni, we had the pleasure of getting to know Matthew as he was at Yale School of Management, and now it is an honor to see him thrive at Connecticut Innovations. As a veteran, Mathew embodies so many of the traits those of us fortunate enough to work with service members know well: laser focus, flawless execution, and a relentless commitment to exceptionality and improvement. This is an allocator to watch! Founder of the Year ?? Sophia Lugo from Radar Therapeutics ?? Sophia, also a Mendoza Impact Fellow Alumni from her time at Stanford University Graduate School of Business got the attention of the entire investment and startup community this year with a $13.3M raise for Radar Therapeutics. Sophia is a dedicated CEO who immediately incorporates feedback and improvement loops into everything she touches, she is an execution-forward CEO, and it is a joy to watch Radar grow under her tenure. Thank you Matthew Archuleta and Sophia Lugo, you both improved our industry in strides in 2024!!! Mendoza Impact Mendoza Ventures Adrian Mendoza Adam Kerr Santiago Santisteban Andres Gomez Le?ero #Boston #SF #startuplife #connecticut #CT
-
-
CEO |Executive Search | Bioscience | Nonprofit | Host "She Leads Biotech" the podcast. | 40+ year veteran of the recruitment industry
A glimpse into the future of genetic medicine. In tomorrows episode of "She Leads Biotech" we explore the transformative potential of genetic medicine with Sophia Lugo the CEO and Chairman of Radar Therapeutics. Founded just five months ago, Radar is revolutionizing the delivery of genetic therapies, with Sophia and her co-founder and CSO Eerik Kaseniit at the forefront of this groundbreaking innovation. Recently awarded the 2024 Biocam California Life Science Catalyst Award, she shares her exhilarating journey in an uncharted field and the unique challenges and triumphs that come with it. Sophia emphasizes the importance of passion in entrepreneurship, reminding us that if you don’t love the problem, you shouldn’t embark on the journey. #biotech #celltherapy #geneticmedicine #startup #sheleadsbiotech #WIB
-
?? We’re thrilled to share that Radar has been honored with the WACKER Biotech Discovery Award! ?? Healthcare innovation should be inclusive of all patients and backgrounds, and we’re proud to bring that vision to life every day. We look forward to collaborating with the WACKER team to propel our mission forward—delivering precisely expressed programmable genetic medicines for all. Join us at the California Life Sciences (CLS) Innovation Showcase on Dec. 10 to learn more about our work and meet our team! #GeneTherapy #LifeSciences #HealthcareInnovation #SyntheticBiology #EquitableHealthcare #CALifeSciences
?? Meet Radar Therapeutics: an innovative leader in genetic medicine and winner of the WACKER Biotech Discovery Award! Its platform for selectively activated mRNAs can precisely control the expression and activity of genetic medicines at the cell type or even cell state level, thereby revolutionizing treatment for a broad array of autoimmune, oncological, and rare diseases. Co-founded by Sophia Lugo, MS, MBA and Dr. Eerik Kaseniit, PhD, Radar Therapeutics emerged from Stanford University and MIT as a pioneering venture that addresses the limitations in current cell and gene therapies—high costs, scalability challenges, and safety risks. As the Wacker Biotech Discovery Awardee, Radar will receive in-kind credits to work with the experienced team at Wacker to develop its advanced therapeutics and advance its mission of accessible genetic medicine for all. Reflecting on her journey, Sophia shared, "I have always been passionate about equitable access to healthcare and innovation. We should innovate with all patients of all backgrounds in mind. I committed my career to solving critical problems and was fortunate to meet Dr. Eerik Kaseniit, a brilliant bioengineer who invented the foundational technology behind RADAR while at Stanford." With backing from leading VCs and pharma, Radar is on a mission to revolutionize programmable medicines. Come meet them at the CLS Innovation Showcase on Dec 10. ?? For more information about the contract development and manufacturing services of Wacker Biotech, please visit https://bit.ly/3AAiKRU and to learn more about Radar Therapeutics and their impact visit https://bit.ly/48vBfDG. #GeneTherapy #LifeSciences #HealthcareInnovation #SyntheticBiology #EquitableHealthcare #CALifeSciences
-
-
Throwback to this incredibly fun interview with our founders, and Anna Rose Welch and Matthew Pillar from Business of Biotech!
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D. https://lnkd.in/evacyGA6 Join us as Anna Rose Welch interviews Radar Therapeutics' founders on their groundbreaking mRNA technology and biotech journey.
-
-
Honored to be named one of 10 Life Science Catalyst Award Winners for 2024 by Biocom California. ?? The award recognizes the "most inspiring and innovative minds dedicated to advancing human health through research, discovery and entrepreneurship, with a commitment to?DEI" under the age of 40. I'm proud to represent Radar Therapeutics and our team of world-class scientists that are truly pushing the boundaries of what is possible for targeted, safe, accessible genetic medicines. It's an honor to work alongside my co-founder and RADAR inventor Eerik Kaseniit on this journey. I was elated to be one of TWO MEXICANAS on the list! ???? ???? I couldn't imagine someone more deserving than Ana Maria Moreno, a trusted mentor and CEO I've looked up to since starting the Radar journey! Shout out to fellow RNA-er David Weinberg as well, whose work the Radar team has admired since before our inception. Full list of winners here: https://bit.ly/3BLIGbt #LifeSciences #CatalystAwards #Innovation #RNA #Biotech
We are thrilled to announce the winners of our ninth annual Life Science Catalyst Awards. The awards celebrate rising and accomplished academics, entrepreneurs, investors, corporate leaders and business advisers who are making significant contributions to the life science industry in California before reaching their 40th birthday. Biocom California selected the 10 winners from an impressive pool of nominees from all facets of the life science industry, including pharma, diagnostics, venture funding, industrial biotech and digital health. In alphabetical order, the Life Science Catalyst Award winners are: ?Denise Bronner, Ph.D., founder and CEO, Empactful Ventures, LLC ?Tyler Brown, Ph.D., founder, chair and president, OUTbio San Diego ?Nick Goeden, Ph.D., co-founder and chief technology officer, Capsida Biotherapeutics ?Michael Henderson, M.D., CEO, Apogee Therapeutics ?Sophia Lugo, co-founder, chairman and CEO, Radar Therapeutics ?Ana Moreno, Ph.D., founder and CEO, Navega Therapeutics ?Nindhana Paranthaman, M.D., executive medical director of clinical development, Summit Therapeutics, Inc. ?Kevin Parker, Ph.D., CEO and co-founder, Cartography Biosciences ?Hunter Reed, vice president, Alexandria Venture Investments at Alexandria Real Estate Equities, Inc. ?David Weinberg, Ph.D., co-founder and CEO, ParcelBio The award winners will be highlighted in the Biocom California LifeLines digital platform and newsletter, on social media platforms and celebrated at our Annual Gala on November 21, 2024. Join us in congratulating this year’s award winners! See the winners here: https://bit.ly/3BLIGbt
-